Do you want to read an article? Please log in or register.
Dynamic Risk of Systemic Complement Activation With Time to Progression to Advanced Age-Related Macular Degeneration
Macular Diseases
Related content
COMMENTED
Macular Diseases
Alcohol Consumption and Risk of Age-Related Macular Degeneration and Geographic Atrophy Progression: AREDS2 Report 34
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Duic C, Vance E, Agrón E, Keenan TDL, AREDS2 Research Group
doi: 10.1016/j.oret.2024.11.006
Macular DiseasesFurther Publications
Curcuma-Based Nutritional Supplements and Risk of Age-Related Macular Degeneration
JAMA Ophthalmol
Alsoudi AF, Wai KM, Koo E, Mruthyunjaya P, Rahimy E
doi: 10.1001/jamaophthalmol.2024.4400
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Janus Kinase Inhibitor Therapy and Risk of Age-Related Macular Degeneration in Autoimmune Disease
JAMA Ophthalmol
Hallak JA, Abbasi A, Goldberg RA, Modi Y, Zhao C, Jing Y, Chen N, Mercer D, Sahu S, Alobaidi A, López FJ, Luhrs K, Waring JF, den Hollander AI, Smaoui N
doi: 10.1001/jamaophthalmol.2024.2376
Macular Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol
Shor R, Mihalache A, Noori A, Shor R, Kohly RP, Popovic MM, Muni RH
doi: 10.1001/jamaophthalmol.2025.1455
Macular Diseases
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Br J Ophthalmol
Vu TA, Fenwick EK, Man REK, Thakur S, Tan ACS, Cheung CMG, Gupta P, Lamoureux EL
doi: 10.1136/bjo-2024-325713
Macular Diseases
Intravitreal anti-vascular endothelial growth factor injections and risks of stroke in patients with neovascular age-related macular degeneration-A registry-based cohort study
Acta Ophthalmol
Falemban AH, Söderberg-Löfdal K, Jonsson F, Almlöf-Sarman S, von Euler M, Westborg I
doi: 10.1111/aos.17534
Macular Diseases
Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence
Sci Rep
Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR
doi: 10.1038/s41598-024-78327-0
Macular Diseases
Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial
JAMA Ophthalmol
Murphy GSP, Saleh A, Ayis S, Cheema MR, Mehta A, Steel DH, Membrey L, Costen M, Jackson TL
doi: 10.1001/jamaophthalmol.2024.4297